Note 9 - Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of Financial Assets and Liabilities Measured on a Recurring Basis

Our financial assets and liabilities measured at fair value on a recurring basis are as follows:


	Fair value measurements as of June 30, 2026
	Quoted
	prices in
	active		Significant
	markets for		other		Significant
	identical		observable		unobservable
	assets		inputs		inputs
(In thousands)	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Money market funds	$	157,414	$	—	$	—	$	157,414
Equity securities		8,050		—		—		8,050
Common stock options		—		3		—		3
Forward contracts		—		223		—		223
Total assets	$	165,464	$	226	$	—	$	165,690


	Fair value measurements as of December 31, 2025
	Quoted
	prices in
	active		Significant
	markets for		other		Significant
	identical		observable		unobservable
	assets		inputs		inputs
(In thousands)	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Money market funds	$	230,625	$	—	$	—	$	230,625
Equity securities		9,268		—		—		9,268
Common stock options/warrants		—		3		—		3
Total assets	$	239,893	$	3	$	—	$	239,896
Liabilities:
Forward contracts		—		230		—		230
Total liabilities	$	—	$	230	$	—	$	230

Summary of Carrying Value and Estimated Fair Value of Notes

The table below presents the carrying amount, estimated fair value, and applicable fair value hierarchy tiers for our 2029 Convertible Notes. The fair value for these notes is determined using directly observable inputs other than quoted prices in active markets.


	June 30, 2026
	Carrying		Total
(In thousands)	Value		Fair Value		Level 1		Level 2		Level 3
2029 Convertible Notes	$	89,807	$	152,650	$	—	$	152,650	$	—

OPKO HEALTH, INC. 10-Q